关注
yan jun
yan jun
MD Anderson Cancer Center, Peking Union Medical College(PHD), China Pharmaceutical University
在 mdanderson.org 的电子邮件经过验证
标题
引用次数
引用次数
年份
The Role of the Liver in Sepsis
LS Yan J1, Li S
Int Rev Immunol 33 (6), 498-510, 2014
524*2014
DEDD interacts with PI3KC3 to activate autophagy and attenuate epithelial–mesenchymal transition in human breast cancer
Q Lv, W Wang, J Xue, F Hua, R Mu, H Lin, J Yan, X Lv, X Chen, ZW Hu
Cancer research 72 (13), 3238-3250, 2012
1822012
TLR4 activity is required in the resolution of pulmonary inflammation and fibrosis after acute and chronic lung injury
HZ Yang, JP Wang, SU Mi, HZ Liu, B Cui, HM Yan, J Yan, Z Li, H Liu, ...
The American journal of pathology 180 (1), 275-292, 2012
1702012
TRB3 links insulin/IGF to tumour promotion by interacting with p62 and impeding autophagic/proteasomal degradations
F Hua, K Li, JJ Yu, XX Lv, J Yan, XW Zhang, W Sun, H Lin, S Shang, ...
Nature communications 6 (1), 7951, 2015
1442015
Toll-like receptor (TLR) 2 and TLR4 differentially regulate doxorubicin induced cardiomyopathy in mice
Y Ma, X Zhang, H Bao, S Mi, W Cai, H Yan, Q Wang, Z Wang, J Yan, ...
PloS one 7 (7), e40763, 2012
1192012
FGL2 as a multimodality regulator of tumor-mediated immune suppression and therapeutic target in gliomas
J Yan, LY Kong, J Hu, K Gabrusiewicz, D Dibra, X Xia, AB Heimberger, ...
Journal of the National Cancer Institute 107 (8), djv137, 2015
1132015
IL‐30 (IL27p28) attenuates liver fibrosis through inducing NKG2D‐rae1 interaction between NKT and activated hepatic stellate cells in mice
A Mitra, A Satelli, J Yan, X Xueqing, M Gagea, CA Hunter, L Mishra, S Li
Hepatology 60 (6), 2027-2039, 2014
1112014
Loss of immunity‐supported senescence enhances susceptibility to hepatocellular carcinogenesis and progression in Toll‐like receptor 2‐deficient mice
H Lin, J Yan, Z Wang, F Hua, J Yu, W Sun, K Li, H Liu, H Yang, Q Lv, ...
Hepatology 57 (1), 171-182, 2013
1102013
Blocking TLR2 activity attenuates pulmonary metastases of tumor
HZ Yang, B Cui, HZ Liu, S Mi, J Yan, HM Yan, F Hua, H Lin, WF Cai, ...
PloS one 4 (8), e6520, 2009
1092009
FGL2 promotes tumor progression in the CNS by suppressing CD103+ dendritic cell differentiation
J Yan, Q Zhao, K Gabrusiewicz, LY Kong, X Xia, J Wang, M Ott, J Xu, ...
Nature communications 10 (1), 448, 2019
872019
Intracellular or extracellular heat shock protein 70 differentially regulates cardiac remodelling in pressure overload mice
WF Cai, XW Zhang, HM Yan, YG Ma, XX Wang, J Yan, BM Xin, XX Lv, ...
Cardiovascular research 88 (1), 140-149, 2010
762010
Regulation of tumor immune suppression and cancer cell survival by CXCL1/2 elevation in glioblastoma multiforme
J Hu, Q Zhao, LY Kong, J Wang, J Yan, X Xia, Z Jia, AB Heimberger, S Li
Science Advances 7 (5), eabc2511, 2021
712021
IL6‐mediated inflammatory loop reprograms normal to epithelial‐mesenchymal transition+ metastatic cancer stem cells in preneoplastic liver of transforming growth factor beta …
A Mitra, J Yan, X Xia, S Zhou, J Chen, L Mishra, S Li
Hepatology 65 (4), 1222-1236, 2017
712017
The duality of Fgl2-secreted immune checkpoint regulator versus membrane-associated procoagulant: therapeutic potential and implications
J Hu, J Yan, G Rao, K Latha, WW Overwijk, AB Heimberger, S Li
International reviews of immunology 35 (4), 325-339, 2016
712016
Toll‐like receptor 4 activity protects against hepatocellular tumorigenesis and progression by regulating expression of DNA repair protein Ku70 in mice
Z Wang, J Yan, H Lin, F Hua, X Wang, H Liu, X Lv, J Yu, S Mi, J Wang, ...
Hepatology 57 (5), 1869-1881, 2013
652013
Discovery of cell surface vimentin targeting mAb for direct disruption of GBM tumor initiating cells
H Noh, J Yan, S Hong, LY Kong, K Gabrusiewicz, X Xia, AB Heimberger, ...
Oncotarget 7 (44), 72021, 2016
552016
Bacillus Calmette-Guerin and TLR4 agonist prevent cardiovascular hypertrophy and fibrosis by regulating immune microenvironment
YY Liu, WF Cai, HZ Yang, B Cui, ZR Chen, HZ Liu, J Yan, W Jin, HM Yan, ...
The Journal of Immunology 180 (11), 7349-7357, 2008
542008
Synthesis, biological evaluation, and molecular modeling of glycyrrhizin derivatives as potent high-mobility group box-1 inhibitors with anti-heart-failure activity in vivo
D Du, J Yan, J Ren, H Lv, Y Li, S Xu, Y Wang, S Ma, J Qu, W Tang, Z Hu, ...
Journal of Medicinal Chemistry 56 (1), 97-108, 2013
402013
The role of fibrinogen-like protein 2 on immunosuppression and malignant progression in glioma
K Latha, J Yan, Y Yang, LV Gressot, LY Kong, G Manyam, R Ezhilarasan, ...
JNCI: Journal of the National Cancer Institute 111 (3), 292-300, 2019
382019
Timing is critical for an effective anti-metastatic immunotherapy: the decisive role of IFNγ/STAT1-mediated activation of autophagy
J Yan, ZY Wang, HZ Yang, HZ Liu, S Mi, XX Lv, XM Fu, HM Yan, ...
PloS one 6 (9), e24705, 2011
382011
系统目前无法执行此操作,请稍后再试。
文章 1–20